Skip to content

Does a Transabdominal Plane Block Decrease Patient Pain After Ventral Hernia Repair?

Transabdominal Plane (TAP) Blocks in Ventral Hernia Repair

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02007096
Enrollment
127
Registered
2013-12-10
Start date
2012-08-31
Completion date
2014-10-31
Last updated
2018-01-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Incisional Hernia, Pain, Postoperative, Postoperative Complications, Umbilical Hernia, Ventral Hernia

Keywords

Transabdominal plane block, ventral hernia, umbilical hernia, incisional hernia, hernia repair

Brief summary

The purpose of this study is to determine if a Transabdominal Plane Block will decrease patient pain and pain medication use after a laparoscopic ventral (ventral, umbilical, incisional) hernia repair with mesh.

Detailed description

Patients coming in for a laparoscopic ventral (ventral, umbilical, incisional) hernia repair with mesh are randomized to either receive a Transabdominal Plane Block injection or a placebo saline injection. The injection will be performed by surgeons under direct visualization during laparoscopic surgery prior to mesh placement. Patients will be followed up post-operatively and after hospital discharge to assess for opioid usage and pain score. Patients in both arms are medically cleared by the surgeon. Currently there are no studies that look at the use of Transabdominal Plane Block in ventral hernia repairs.

Interventions

0.25% bupivacaine injection in 6 different locations in abdomen. Weight \<100kg: 50ml total; weight \>100kg: 60ml total

DRUGNon Transabdominal Plane Block

Saline injection in 6 different locations in abdomen. Weight \<100kg: 50ml; weight \>100kg: 60ml

Sponsors

Icahn School of Medicine at Mount Sinai
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* age 18 and older * elective laparoscopic ventral (ventral, umbilical, incisional) hernia repair at Mount Sinai Hospital

Exclusion criteria

* age younger than 18 * allergic reaction to bupivacaine * allergic reaction to opioids * opioid substance abuse

Design outcomes

Primary

MeasureTime frameDescription
Post-operative Opioid Useup to 24 hoursAmount of opioids used by patients at certain time points.

Secondary

MeasureTime frameDescription
Pain Score1 hour postoperativelyPost-operative Patient Self-Reported Pain Score. Patient self-reported pain scores when resting and when actively moving. Scale of 0 to 10, with 0 being no pain and 10 being the most pain you have ever experienced.
Operating Procedure TimeProcedure begin time to procedure end timeTotal number of minutes for the procedure, not including anesthesia time.

Countries

United States

Participant flow

Recruitment details

Participants recruited from the Department of Surgery at The Mount Sinai Hospital between November 2012 and October 2014.

Participants by arm

ArmCount
Transabdominal Plane Block
Transabdominal Plane Block with 0.25% bupivacaine
52
Non Transabdominal Plane Block
Non Transabdominal Plane Block: Saline injection
48
Total100

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall Studyconverted to open surgery11
Overall Studydid not follow postoperative protocol811
Overall Studydid not inject saline03
Overall Studymedication not available20
Overall Studyno mesh placed01

Baseline characteristics

CharacteristicTotalTransabdominal Plane BlockNon Transabdominal Plane Block
Age, Continuous53.22 years
STANDARD_DEVIATION 13.11
52.67 years
STANDARD_DEVIATION 12.89
53.81 years
STANDARD_DEVIATION 13.45
ASA class
1
13 Participants7 Participants6 Participants
ASA class
2
48 Participants24 Participants24 Participants
ASA class
3
36 Participants20 Participants16 Participants
ASA class
4
3 Participants1 Participants2 Participants
BMI31.03 kg/m^2
STANDARD_DEVIATION 6.21
30.91 kg/m^2
STANDARD_DEVIATION 5.45
31.16 kg/m^2
STANDARD_DEVIATION 7
Coronary artery disease15 Participants6 Participants9 Participants
Diabetes19 Participants10 Participants9 Participants
GERD25 Participants12 Participants13 Participants
Hernia defect size39.12 cm^2
STANDARD_DEVIATION 51.99
38.46 cm^2
STANDARD_DEVIATION 42.26
39.84 cm^2
STANDARD_DEVIATION 61.27
Hyperlipidemia34 Participants14 Participants20 Participants
Hypertension48 Participants25 Participants23 Participants
Location of hernia defect
Epigastric
41 Participants23 Participants18 Participants
Location of hernia defect
Infraumbilical
9 Participants2 Participants7 Participants
Location of hernia defect
Lateral
11 Participants8 Participants3 Participants
Location of hernia defect
Umbilical
39 Participants19 Participants20 Participants
LOS
<2 days
71 Participants35 Participants36 Participants
LOS
≥2 days
29 Participants17 Participants12 Participants
Previous abdominal surgery72 Participants41 Participants31 Participants
Sex: Female, Male
Female
48 Participants27 Participants21 Participants
Sex: Female, Male
Male
52 Participants25 Participants27 Participants
Smoker32 Participants15 Participants17 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 00 / 0
serious
Total, serious adverse events
0 / 00 / 0

Outcome results

Primary

Post-operative Opioid Use

Amount of opioids used by patients at certain time points.

Time frame: up to 24 hours

ArmMeasureGroupValue (MEAN)Dispersion
Transabdominal Plane BlockPost-operative Opioid Useat 24 hours25.64 mgStandard Deviation 0
Transabdominal Plane BlockPost-operative Opioid Useat 12 hours16.09 mgStandard Deviation 0
Transabdominal Plane BlockPost-operative Opioid Useat 18 hours20.70 mgStandard Deviation 0
Transabdominal Plane BlockPost-operative Opioid Useat 6 hours10.59 mgStandard Deviation 0
Non Transabdominal Plane BlockPost-operative Opioid Useat 24 hours42.56 mgStandard Deviation 0
Non Transabdominal Plane BlockPost-operative Opioid Useat 6 hours15.62 mgStandard Deviation 0
Non Transabdominal Plane BlockPost-operative Opioid Useat 18 hours39.37 mgStandard Deviation 0
Non Transabdominal Plane BlockPost-operative Opioid Useat 12 hours32.24 mgStandard Deviation 0
Secondary

Operating Procedure Time

Total number of minutes for the procedure, not including anesthesia time.

Time frame: Procedure begin time to procedure end time

ArmMeasureValue (MEAN)Dispersion
Transabdominal Plane BlockOperating Procedure Time97.41 minStandard Deviation 30.22
Non Transabdominal Plane BlockOperating Procedure Time98.81 minStandard Deviation 37.51
Secondary

Pain Score

Post-operative Patient Self-Reported Pain Score. Patient self-reported pain scores when resting and when actively moving. Scale of 0 to 10, with 0 being no pain and 10 being the most pain you have ever experienced.

Time frame: 1 hour postoperatively

ArmMeasureGroupValue (MEAN)Dispersion
Transabdominal Plane BlockPain Scorepain scores at rest5.19 units on a scaleStandard Deviation 0.39
Transabdominal Plane BlockPain Scorepain scores with movement6.15 units on a scaleStandard Deviation 0.42
Non Transabdominal Plane BlockPain Scorepain scores at rest6.46 units on a scaleStandard Deviation 0.38
Non Transabdominal Plane BlockPain Scorepain scores with movement7.73 units on a scaleStandard Deviation 0.4
Secondary

Pain Score

Post-operative Patient Self-Reported Pain Score. Patient self-reported pain scores when resting and when actively moving. Scale of 0 to 10, with 0 being no pain and 10 being the most pain you have ever experienced.

Time frame: 24 hours postoperatively

ArmMeasureGroupValue (MEAN)Dispersion
Transabdominal Plane BlockPain Scorepain scores at rest4.60 units on a scaleStandard Deviation 0.39
Transabdominal Plane BlockPain Scorepain scores with movement6.75 units on a scaleStandard Deviation 0.38
Non Transabdominal Plane BlockPain Scorepain scores at rest4.52 units on a scaleStandard Deviation 0.31
Non Transabdominal Plane BlockPain Scorepain scores with movement6.98 units on a scaleStandard Deviation 0.4

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026